GNC Unleashes Beyond Raw's Next-Generation Advanced Pre-Workout
LIT AF V2 combines VELOX® and HydroNOx™ for an industry-first formula that delivers massive pumps, sustained energy and real results.
LIT AF V2 is the only pre-workout on the market combining VELOX®, a clinically superior arginine and citrulline blend, with HydroNOx™, a more efficient citrulline hydrochloride, creating an unprecedented dual-powered nitric oxide system. This 1-2 punch delivers clinically dosed muscle pump, and unmatched performance for the most discerning pre-workout user.
Beyond the dual pump system, LIT AF V2 delivers a fully transparent, clinically optimized formula including 300mg dual-release caffeine (250mg caffeine anhydrous + 50mg ZumXR® extended release caffeine) for sustained high-stim energy that powers lifters from warmup to final rep, 250mg Cognizin® for locked-in focus, 50mg Senactiv® to fuel high-intensity work, upgraded 3g creatine monohydrate for more muscle-building power and superior strength output, plus 300mg electrolytes and 50mg AstraGin® to ensure your body absorbs and uses every ingredient.
"LIT AF V2 isn't just a refresh. It's a complete reset for the experienced pre-workout users who've tested multiple pre-workouts, and who set the bar high," said
This new formula is now available exclusively at GNC.com, GNC stores and TikTok Shop for
About GNC
GNC is an American-run global leader in health and wellness delivering science-based products and solutions designed to help consumers Live Well. With over 96% of GNC branded products being manufactured in
Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/gnc-unleashes-beyond-raws-next-generation-advanced-pre-workout-302784094.html
SOURCE GNC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MY DR NOW Tackles Long Wait Times with 10th Phoenix Clinic at 7th Street & Glendale
- NCLA 250: Administrative State Founder James Landis Awarded Bureaucracy’s Highest Dishonor
- GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share